Opnurasib
Chemical Structure Depiction of
Opnurasib
Opnurasib
Compound characteristics
| Compound ID: | CE04-4332 |
| Compound Name: | Opnurasib |
| Molecular Weight: | 526.04 |
| Molecular Formula: | C29 H28 Cl N7 O |
| CAS Number: | 2653994-08-0 |
| Smiles: | Cc1cc2c(cn[nH]2)c(c2c(c3ccc4c(c3)cnn4C)nn(C3CC4(C3)CN(C4)C(C=C)=O)c2C)c1[Cl] |
| InChI Key: | AZUYLZMQTIKGSC-UHFFFAOYSA-N |
| Short Description: | Opnurasib (JDQ-443) is an orally available and selective and potent covalent KRAS G12C inhibitor with antitumor activity for the study of advanced non-small cell lung cancer. |
| Pathway: | GPCR/G Protein|||MAPK |
| Target: | Ras |
| Type of molecule: | Clinical |
| Alias: | JDQ-443 , Opnurasib , NVP-JDQ443 |
| Stock amount: | 331 |